Novosanis is a wholly owned subsidiary of OraSure Technologies Inc (NASDAQ: OSUR) and an innovative developer and producer of medical devices improving the quality of diagnostic tests for infectious diseases and oncology.
Collaborate with us in the fight against the spread of monkeypox
The monkeypox (MPX) outbreak is an evolving global health threat. WHO and the Biden administration have declared the outbreak a global health emergency and public health emergency , respectively. As we have learned from the COVID-19 pandemic, screening and early testing are critical strategies for...
Association for Molecular Pathology 2022 (AMP)
We will be at the Association for Molecular Pathology (AMP) 2022 Annual Meeting & Expo, which will take place November 1-5 in Phoenix, Arizona. At the conference, our team can tell you more about the benefits of non-invasive sample types such as urine in oncology and infectious disease testing...